Canada markets close in 3 hours 11 minutes

Sino Biopharmaceutical Limited (SBMFF)

Other OTC - Other OTC Delayed Price. Currency in USD
Add to watchlist
0.31490.0000 (0.00%)
As of 09:47AM EDT. Market open.
Currency in USD

Valuation Measures4

Market Cap (intraday) 6.48B
Enterprise Value 6.27B
Trailing P/E 22.33
Forward P/E 18.08
PEG Ratio (5 yr expected) N/A
Price/Sales (ttm)1.62
Price/Book (mrq)1.41
Enterprise Value/Revenue 0.24
Enterprise Value/EBITDA 0.90

Trading Information

Stock Price History

Beta (5Y Monthly) 0.52
52-Week Change 3-38.48%
S&P500 52-Week Change 323.57%
52 Week High 30.5400
52 Week Low 30.3149
50-Day Moving Average 30.3585
200-Day Moving Average 30.3840

Share Statistics

Avg Vol (3 month) 3885
Avg Vol (10 day) 3150
Shares Outstanding 518.79B
Implied Shares Outstanding 620.59B
Float 89.28B
% Held by Insiders 148.19%
% Held by Institutions 115.69%
Shares Short 4N/A
Short Ratio 4N/A
Short % of Float 4N/A
Short % of Shares Outstanding 4N/A
Shares Short (prior month ) 4N/A

Dividends & Splits

Forward Annual Dividend Rate 40.01
Forward Annual Dividend Yield 42.03%
Trailing Annual Dividend Rate 30.05
Trailing Annual Dividend Yield 314.29%
5 Year Average Dividend Yield 41.47
Payout Ratio 472.63%
Dividend Date 3Dec 15, 2017
Ex-Dividend Date 4Jun 11, 2024
Last Split Factor 23:2
Last Split Date 3Jun 04, 2018

Financial Highlights

Currency in CNY.

Fiscal Year

Fiscal Year Ends Dec 31, 2023
Most Recent Quarter (mrq)Dec 31, 2023

Profitability

Profit Margin 8.90%
Operating Margin (ttm)20.76%

Management Effectiveness

Return on Assets (ttm)5.33%
Return on Equity (ttm)12.12%

Income Statement

Revenue (ttm)26.2B
Revenue Per Share (ttm)1.41
Quarterly Revenue Growth (yoy)N/A
Gross Profit (ttm)N/A
EBITDA 6.38B
Net Income Avi to Common (ttm)1.85B
Diluted EPS (ttm)0.0100
Quarterly Earnings Growth (yoy)N/A

Balance Sheet

Total Cash (mrq)14.12B
Total Cash Per Share (mrq)0.77
Total Debt (mrq)12.72B
Total Debt/Equity (mrq)33.31%
Current Ratio (mrq)1.05
Book Value Per Share (mrq)1.66

Cash Flow Statement

Operating Cash Flow (ttm)6.07B
Levered Free Cash Flow (ttm)3.01B